The Prospective Segeberg TAVI Registry

N/ARecruitingNCT03192774

Segeberger Kliniken GmbH2,000 enrolled

Overview

A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany

A prospective single center registry including all patients treated with transcatheter aortic valve implantation (TAVI) at the Heart Center, Bad Segeberg, Germany. Patients undergo a routine clinical and echocardiographic follow-up schedule, including a long-term follow-up plan beyond 5 years to assess valve durability.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Aortic Valve Stenosis

Interventions

Transcatheter Aortic Valve ImplantationDEVICE

Interventional replacement of the aortic valve

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients treated with TAVI Exclusion Criteria: * None

Locations (1)

Heart Center, Segeberger Kliniken

Bad Segeberg, Germany

RECRUITING

Outcomes

Primary Outcomes

Mortality

Cardiovascular and not cardiovascular death

Time frame: Up to 10 years

Secondary Outcomes

Structural valve deterioration

Transprosthetic mean pressure gradient ≥40 mmHg and/or ≥20 mmHg rise from baseline OR severe intraprosthetic aortic regurgitation

Time frame: Up to 10 years

Central Contacts

Mohamed Abdel-Wahab, MD

CONTACT

msabdelwahab@gmail.com

Ralph Toelg

CONTACT

ralph.toelg@segebergerkliniken.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.